Mounjaro and Glaucoma: What We Know (October 2026)

01 · The short answer

Can Mounjaro cause glaucoma?

Glaucoma is not listed as a side effect in the UK patient leaflet.

You may see online summaries claiming that tirzepatide lowers or raises the risk of glaucoma. Studies of that kind compare groups of people and can only show an association. They cannot show that a medicine caused a change in eye health, because people given different medicines often differ in age, diabetes status, weight and eye history.

Your prescriber and eye specialist can weigh your eye history, your pressure readings and your wider health.

02 · Is this relevant to you?

What to do if you have glaucoma, or a family history of it

If you have a glaucoma diagnosis, the sensible step is to tell the prescriber who reviews your Mounjaro order. Mounjaro is a prescription-only medicine, supplied after an online consultation reviewed by a GPhC-registered prescriber.¹ A prescriber can only judge suitability on what they are told, so list your eye condition and every eye drop or tablet you use for it.

It also helps to tell your eye specialist that you are considering Mounjaro or have started it. They look after your pressure monitoring and treatment plan, and they may want to review you at a particular point. Do not change or stop glaucoma treatment because of anything you read here. Those decisions belong to the specialist who knows your eyes.

If glaucoma runs in your family but you have not been diagnosed, keep up regular eye tests. Weight-management treatment does not replace routine eye care. Attending your appointments matters more than any online reassurance, because glaucoma often causes no early symptoms you would notice yourself.

If you want a more direct answer on taking treatment alongside an existing diagnosis, read about whether you can take it if you already have glaucoma. If you are ready to find out whether Mounjaro is suitable, you can start a free consultation through the Mounjaro pen page. Our wider weight loss clinic page explains the full service.

Related guides: Rowe glp1 and Mounjaro butt and Mounjaro babies.

Related guide: Mounjaro biosimilar.

03 · Known side effects

Is glaucoma a listed side effect of Mounjaro?

The recognised side effects are set out in the Summary of Product Characteristics and in the patient information leaflet that comes with every pen.¹¹³ Those documents are the proper reference, because they are reviewed by the medicines regulator and updated as evidence develops.

It is worth being precise about what that statement means. Saying a condition is not listed as a side effect in the UK patient leaflet is different from saying it can never happen to anyone who takes the medicine. People develop eye conditions for many reasons, and some of those people will also be taking Mounjaro by coincidence. A clinical trial or a regulator is the route by which a true link is identified. A social media thread or a news headline is not.

If you read a post saying that Mounjaro has affected someone's eyes, the right response is not alarm and not dismissal. It is to read the leaflet, note any change in your own vision and speak to a clinician if you see one.

How the leaflet helps you

The leaflet lists the effects people should look out for and tells you when to seek help. Read it before your first dose and keep it with your pen. If you have an eye condition, take it to your next eye appointment so your specialist can see what you are taking. It takes a few minutes and can prevent misunderstandings later.

What to do if you notice something new

Tell your prescriber about any new symptom, whether or not you think the medicine is responsible. You can also report a suspected side effect yourself through the MHRA Yellow Card scheme.¹⁹ Reports from patients and clinicians are how regulators spot patterns that individual trials miss, so a report is useful even if you are unsure of the cause.

If the symptom involves your eyes and comes on suddenly, do not wait for an email reply. Get medical help straight away, through an eye casualty department, NHS 111 or emergency services depending on severity. Online messaging is for non-urgent questions.

Finally, keep your pen details and batch information to hand when you report. It makes a Yellow Card report more useful to the people who review it.

04 · How it works

How Mounjaro works, and why that matters here

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly.¹ Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹ Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ That is the purpose of the treatment. It acts on appetite and on how the body handles food and insulin.

This dual action is what distinguishes Mounjaro from single-action medicines such as semaglutide, sold as Wegovy and Ozempic.¹ Ozempic is semaglutide licensed for type 2 diabetes — it is not a UK weight-loss medicine, and prescribing it privately for weight loss is off-label. Each medicine has its own product information, so a finding about one should not be assumed to apply to another.

Why people link the two topics

People understandably wonder about eyes when a medicine changes how the body handles food, fluid and blood sugar. Those changes are real, and they are the reason your prescriber reviews you regularly. But a plausible-sounding link is not evidence.

Clearance from the body

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹

For anyone with a long-term eye condition, the practical message is simple. Keep your specialist informed, keep taking the treatment they prescribe and let the two clinical teams work from the same facts.

05 · Research headlines

How to read research headlines about eyes and weight-loss injections

Headlines about weight-loss injections and eye health appear regularly, and they point in different directions. Some suggest a possible benefit, some a possible risk. The sensible reaction to both is the same: ask what kind of study it was and what it can actually show.

Many of these reports come from observational research. Researchers look at large records of people who happened to receive different medicines and compare outcomes. That can generate useful questions, but it cannot prove that a medicine caused a difference. People prescribed one medicine often differ from people prescribed another in age, weight, diabetes control and other health conditions, and those differences can create apparent effects on their own.

Questions worth asking

• Was this a randomised trial, or a comparison of existing records?
• Did it study people with diabetes, people living with obesity, or both?
• Was the result about developing a condition, or about people who already had it?
• Has the finding been confirmed by other independent groups?
• Does the regulator's product information mention it?

If the answers are unclear, hold the finding lightly. A headline can start a conversation with your specialist, but it should not change your treatment on its own.

What does carry weight

The regulator's product information, your own eye examination results and your specialist's judgement carry the most weight for you personally. If a new finding genuinely changes the picture, those sources will reflect it in time. In the meantime, a free conversation with a prescriber or eye specialist costs you nothing and is worth more than a dozen forum threads.

It is also fine to say you are unsure. Clinicians would rather answer a question that turns out to be nothing than hear about a problem late.

06 · Telling your clinicians

What to tell your prescriber and your eye specialist

Tell your Mounjaro prescriber about any eye condition, and tell your eye specialist about Mounjaro. Mounjaro is a prescription-only medicine supplied after an online consultation reviewed by a GPhC-registered prescriber.¹ Our consultation is free, short and carries no obligation. It is a health questionnaire, followed by a review by a prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

What to tell the Mounjaro prescriber

• Your glaucoma diagnosis, including the type if you know it.
• Every eye drop, tablet or other treatment you use, and who prescribes it.
• Any other eye conditions, and any eye surgery or laser treatment you have had.
• Whether you have diabetes, and whether you attend diabetic eye screening.
• Any other medicines, including over-the-counter products and supplements.

Give accurate answers even if you worry it might affect the outcome. The prescriber's job is to protect you, and an incomplete picture is the biggest risk to a safe decision.

What to tell the eye specialist

• That you are starting, or already taking, once-weekly tirzepatide.
• The dose you are on and when it last changed.
• Any new visual symptoms since you started.
• That you would like them to flag anything they notice at your next check.

Your specialist may already know a good deal about weight-loss injections, or may want to read the product information first. Either way, they now have the full picture.

Ongoing support

Our aftercare includes ongoing monthly reviews, dose titration and follow-up assessments by the prescribing team, plus side-effect support. Repeat orders re-check suitability, and nothing ships automatically. That means you have regular opportunities to mention a change in your eyes or in your eye treatment. Use them. If your specialist changes your glaucoma treatment, update us at the next review.

Support is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat or by phone on 0333 207 0413. For anything urgent affecting your sight, get medical help straight away through NHS services instead of waiting for a reply.

07 · New eye symptoms

What to do about new eye or vision symptoms

Any sudden or worrying change in your vision needs you to get medical help straight away, whatever medicines you take. Do not wait to see whether it settles, and do not assume it is connected or unconnected to Mounjaro. A clinician can examine your eyes and find the actual cause, which a web page cannot.

Symptoms that should not wait

• Sudden loss of vision, or a curtain or shadow across your sight: get medical help straight away.
• Severe eye pain, especially with redness, headache or feeling sick.
• Seeing halos around lights that is new for you.
• A sudden shower of floaters or flashes of light.

These need you to get medical help straight away. Go to an eye casualty department, call NHS 111 or call 999, depending on how severe things are. Tell them you take a once-weekly injection and show them the pen or leaflet.

Symptoms to raise at your next review

Milder changes, such as vision that seems less sharp than before, dry or tired eyes, or difficulty with reading, deserve a conversation too. Mention them to your prescriber and arrange an eye test. Many causes are common and easily treated, and an optometrist can check your pressure and the health of the back of your eye.

Glaucoma is not listed as a side effect in the UK patient leaflet, but tell your prescriber about any new or lasting symptom and report it through the Yellow Card scheme.

Reporting through Yellow Card

You can report any suspected side effect through the MHRA Yellow Card scheme, whether or not you are sure of the cause.¹⁹ You do not need to be a clinician to do so. Include the medicine name, the dose, when you started, what you noticed and any other medicines you take. It is a quick way to add to the national picture of how medicines behave.

Keep a short note of when symptoms started and any changes to doses. It helps both the eye specialist and the prescriber.

08 · Diabetes and eyes

Diabetes, weight and eye health: the wider picture

If you have diabetes, eye screening is part of your routine care, and it matters whichever medicines you take. Mounjaro is licensed in the UK for type 2 diabetes as well as for weight management, and NICE has issued guidance on tirzepatide for type 2 diabetes.¹⁸ Always keep your screening appointments, because they check the back of the eye for changes that would not cause symptoms early on.

Glaucoma and diabetic eye disease are different

Glaucoma and diabetic eye disease are different conditions with different monitoring. Someone can have one, the other, both or neither. If you have diabetes and glaucoma together, make sure each of your clinical teams knows about the other condition, because screening services and eye clinics do not always share information automatically.

That is a conversation for your diabetes team and your eye specialist, ideally together.

Food and lifestyle questions

Questions about foods to avoid, helpful fruit or lifestyle changes for glaucoma come up often. Your eye specialist, an optometrist or the NHS pages on glaucoma are better places to look, and they can tailor advice to you.

Stay within the licence

Mounjaro is used alongside a reduced-calorie diet and increased physical activity, and individual results vary.¹ It is not an eye treatment and should never be taken for one.

09 · What treatment is for

What Mounjaro is for, and what the trial evidence says

Mounjaro is licensed for weight management in adults and for type 2 diabetes, and its trial evidence is about weight. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight.² Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

Weighing benefit and uncertainty

If you have glaucoma, your decision involves two things. One is the benefit you hope to gain from weight management. The other is the uncertainty around your own eye health, which your specialist is best placed to judge. A clear conversation with both clinicians lets you weigh those together rather than guess.

Treatment is a course, not a quick fix

Dose changes happen gradually, stepping up through the available strengths under prescriber review. People differ in how they respond, and some stay on a lower dose. Your prescriber will discuss what is appropriate for you, and your eye care continues unchanged throughout.

If at any point you feel the treatment is not right for you, contact the prescribing team. Stopping should always be planned with your prescriber. Tirzepatide takes roughly 4–5 weeks to clear the system.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹ If you are pregnant or planning a pregnancy: Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you use the contraceptive pill, switch to a non-oral method or add a barrier method (such as condoms) for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.

11 · NHS and private

NHS or private: getting Mounjaro if you have an eye condition

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

Having an eye condition does not change the route

Whether you go through the NHS or a private pharmacy, a clinician should review your whole health history, including any glaucoma. Ask your GP whether you are eligible under the NHS rollout, and tell them about your eye care. If you choose private treatment, the same disclosure applies, and our prescribers review it as part of the consultation.

Choosing a regulated supplier

Whichever route you take, buy only from a registered pharmacy. EverydayMeds is a GPhC-registered UK online pharmacy, registration 9012878, and you can verify that on the GPhC register.¹² We supply genuine Mounjaro KwikPens through official LillyDirect supply, sourced directly from Eli Lilly. Be wary of anyone offering to supply without a consultation or prescription, because that is a warning sign of an unsafe or counterfeit product.⁷

How ordering works

You complete a free online consultation, a GPhC-registered prescriber reviews it, and our registered pharmacy dispenses the order. Delivery is free, next-day and tracked, in temperature-controlled packaging, with same-day dispatch when ordered by 3pm. Saturday delivery is £14.99. Needles, a sharps bin and injection guidance come with every order.